· Volume surge · NVO
Novo Nordisk A/S (NVO) draws heavier tape as 12-week rebound reaches 30.0%
The healthcare heavyweight is recovering in weekly context, but Relative Strength remains negative and the trend signal has not reactivated.
Novo Nordisk A/S (NVO) closed at 48.07 USD in the latest week, adding 11.3% over one week and 5.5% over four weeks. The active-mover screen also flagged turnover at 2.3x, showing expanded participation behind the move.
The evidence is still mixed. Market Dynamics showed confirmation at 0.75, but the trend signal was inactive and Relative Strength stood at -9.5, leaving the weekly setup improved but not broadly confirmed.
The chart view is a weekly price path over 52 weeks, so it frames the rebound in longer-term context rather than live intraday trading.